Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose-response Study of the Effects of Exendin-9,39 on Gastrointestinal Symptoms and Food Intake.

NCT02128581 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02128581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02128581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose-response Study of the Effects of Exendin-9,39 on Gastrointestinal Symptoms and Food Intake.
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2014
Completion date
July 31, 2019
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, obesity, roux-en-y gastric bypass